PsyIndex Weekly Update – December 7, 2020 – December 11, 2020

Market Performance

• Ehave Inc.
  (OTC: EHVVF)
  0.062 +0.355 (136.54%)
• Pharmadrug Inc.
  (CSE: BUZZ)
  0.080 +0.045 (128.57%)
• New Wave Holdings Corp.
  (CSE: SPOR)
  0.165 +0.090 (120.00%)

• Nova Mentis Life Science Corp.
  (CSE: NOVA)
  0.305 -0.055 (-15.28%)
• Empower Clinics Inc.
  (CSE: CBDT)
  0.275 -0.025 (-8.33%)

Corporate News, Deals & Listings

• Tryp Therapeutics filed a final prospectus and announced its initial public offering. Press Release
• Cybin Corp. signed a definitive agreement to acquire Adelia Therapeutics as part of its commitment to strategic growth. Press Release
• Psyched Wellness Ltd. (CSE: PSYC) announced a positive toxicology assessment and provided a path to market for a legal psychedelic mushroom product. Press Release
• Psyched Wellness Ltd. (CSE: PSYC) also added Aaron Slater to its Advisory Board. Press Release
• Psyched Wellness Ltd. (CSE: PSYC) also completed writing the final extraction protocol and other details for its first product. Press Release
• Revive Therapeutics Ltd. (CSE: RVV) added Dr. Joel Moody, an epidemiologist, as a Medical and Clinical Advisor. Press Release
• Numinus Wellness Inc. (TSX-V: NUMI) announced a $10 million bought deal public offering. Press Release
• Mydecine Innovations Group (CSE: MYCO) plans to make the first commercial export of legal psilocybin mushrooms. Press Release
• Havn Life Sciences Inc. (CSE: HAVN) will supply psychedelic compounds to clinical studies focused on veterans and PTSD. Press Release
• Mind Cure Health Inc. (CSE: MCUR) announced a translational research program with a focus on psychedelic compounds. Press Release
• Mind Cure Health Inc. (CSE: MCUR) also announced that it was moving into psychedelic assisted therapy in British Columbia. Press Release
• PharmaTher Inc. (CSE: PHRM) was granted a pre-IND meeting with the FDA for ketamine targeting Parkinson’s disease. Press Release
• Entheon Biomedical Corp. (CSE: ENBI) announced a DMT drug supply agreement with Psygen Labs. Press Release
• Pure Extracts Technologies Corp. (CSE: PULL) signed a letter of intent with The Nutraceutical Medicine Company. Press Release
• BetterLife Pharma Inc. (CSE: BETR) added a next-gen psychedelic therapy to its pipeline of drugs. Press Release
• Field Trip Health Ltd. (CSE: FTRP) increased its bought-deal financing to $17.4 million. Press Release

Featured Content

3 Ways to Invest in Psychedelic IP

The psychedelics industry has experienced a renaissance over the past two years with the launch of the Johns Hopkins Center for Psychedelic Research and a billion-dollar IPO. While there are many ways to capitalize on the industry, intellectual property will play a key role in both protecting assets and becoming a potential source of revenue.

We take a look at three companies that aim to build an intellectual property portfolio in the space.

Experts Weigh in on Industry Opportunities at CanndoraConnect

Canndora, a global media and event platform, and initiative created by Marigold Marketing & PR to support advancing women in emerging industries, hosted #CanndoraConnect: Women in Psychedelics on December 2nd, 2020. The event featured eight industry professionals and sold out with over 100 registrants from around the world.

Industry Developments

• Psychedelics Re-Engineered for Potential Use in the Clinic via Nature
• LSD vs. Mushrooms: Same But Different via Healthline
• This is How Psychedelics Hack the Brain, According to Scientists via Vice